跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 15,174 条关于
“RAS/MAPK pathway”
全部
15,174
临床试验
6,614
药物
638
机构
244
资讯
7,678
去年
Trametinib Shows Promise in Treating Severe Hypertrophic Cardiomyopathy in Children
3年前
Lorlatinib Shows Promise in ALK-Driven Refractory Neuroblastoma with Emerging Resistance Mechanisms Identified
9个月前
Verastem Oncology Restructures Leadership to Advance KRAS-Targeted Cancer Pipeline
去年
Immuneering Partners with Lilly for Phase 2 NSCLC Combination Trial Testing Dual MAPK Pathway Blockade
去年
Verastem Oncology to Present New LGSOC Treatment Data at SGO 2025 Annual Meeting
2年前
Verastem's Avutometinib and Defactinib Combination Therapy Shows Promise in LGSOC and Other Cancers
去年
Pasithea Therapeutics Raises $6.3 Million to Advance MEK Inhibitor for Neurofibromatosis Type 1
8个月前
Verastem Discontinues KRAS G12C Trial to Focus on Promising G12D Inhibitor with 69% Response Rate
去年
Erasca's Naporafenib Shows Promise in NRAS-Mutant Melanoma, RAS Targeting Franchise Advances
去年
Vividion Therapeutics Initiates Phase I Trial of Novel RAS-PI3Kα Inhibitor for Advanced Solid Tumors
第 1 页,共 768 页
上一页
下一页